Introducing the new AltIndexLearn more

Abbott Laboratories (ABT) Stock Analysis: AI Score & Alternative Data

NYSE · Health Care Services · 18 members have ABT in their Portfolio →
Price
$107.81 -0.14%
AI Score
61Buy
Earnings
Oct 20
Market Cap
$187B
PE Ratio
34.3
52w Range
$82 – $134
$107.81 -0.14% vs prev close
ABT Stock Price vs. AI Score Data gathered: August 8
3M +28.8%
61/100 AI Score
Buy
Brand
30/100
Employment
61/100
User Growth
70/100
Fundamental
83/100

Today's AI read on ABT

ABT alt-data: revenue climbing, job postings lagging

Is Abbott Laboratories a buy right now? The alternative data leans yes. This ABT stock analysis is built on the 25+ alternative data signals AltIndex tracks on Abbott Laboratories every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 61/100: a Buy. The stock trades at $107.81 with a $187B market cap.

What’s driving the buy signal over the past 90 days: revenue up 7.7% YoY to $11.2B, headcount (according to LinkedIn) up 12.0% to 151K employees, and sentiment up 135.7% to 66/100. The watch-item: job postings down 36.5% to 2K open roles, and Reddit mentions down 37.5% to 5 a day.

ABT’s broader alt-data profile also covers web traffic (873K monthly visits), business outlook (61% of employees positive), and Facebook followers (413K). Every signal links to its own page with full history, the ABT technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on ABT is just below.

Abbott Laboratories AI Stock Analysis

Abbott Laboratories (ABT) is a globally diversified healthcare company headquartered in Illinois, USA. The company develops and manufactures a broad range of healthcare products, including medical devices, diagnostics, branded generic pharmaceuticals, and nutritional products.

Analysis generated August 1, 2026.

Read the full ABT deep-dive
Fundamentals, alt-data signals and the full methodology, refreshed daily.
Read full analysis

Recent Abbott Laboratories Stock Alerts

Abbott Laboratories logo Abbott Laboratories | July 29
Sentiment is up by 32.2% in the last couple of days.
Abbott Laboratories logo Abbott Laboratories | July 18
Sentiment is up by 18.5% in the last couple of days.
Abbott Laboratories logo Abbott Laboratories | July 16
Price is up by 10.7% in the last 24h.
Abbott Laboratories logo Abbott Laboratories | July 13
Rick Larsen (member of U.S. congress) is selling shares
Get ABT alerts in real-time
The moment Reddit spikes, sentiment flips, or insiders trade.
Sign up

Abbott Laboratories Alternative Data

Alternative Data Value 3m Change Trend
Webpage Traffic 873K 2.0%
Job Posts 2K 36.5%
LinkedIn Employees 151K 12.0%
Employee Recommend 69 0%
Business Outlook 61 3.2%
Lobbying Cost $300K 0%
Sentiment 66 135.7%
Reddit Mentions 5 37.5%
X Mentions 21 54.3%
Stocktwits Mentions 7 97.6%
News Mentions 3 200.0%
Stocktwits Subscribers 18K 1.6%
4chan Mentions 0 N/A
X Followers 124K 0%
Instagram Followers 322K 2.5%
Facebook Followers 413K 0.6%
Facebook Engagement 489 79.7%

About Abbott Laboratories (ABT)

Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.

Abbott Laboratories logo
Price$107.81
Target Price$387.74
Volume63,420,177
Market Cap$187B
Year Range$82 – $134
Dividend Yield0%
PE Ratio34.3
Analyst Rating38% buy
IndustryHealth Care Services

Latest Abbott Laboratories News

View more →

Abbott Laboratories Earnings & Financial Performance

View all earnings →

Abbott Laboratories Insider Trading Activity

View all →
Stratton John G filed to sell 23,319 shares at $0.0.
May 7 '26
STARKS DANIEL J filed to sell 6,751,103 shares at $0.0.
Apr 27 '26
Boudreau Philip P filed to sell 2,200 shares at $0.0.
Apr 23 '26
Salvadori Daniel Gesua Sive filed to sell 146,377 shares at $0.0.
Mar 2 '26
MCCOY JOHN A. JR. filed to sell 24,628 shares at $0.0.
Mar 2 '26

Abbott Laboratories Congress Trading

View all →
Politician Filing Date Type Size
Rick Larsen
Jul 13, 26 Sell $8K+
Rich McCormick
Jul 10, 26 Buy $8K+
Ro Khanna
Jul 8, 26 Buy $8K+
Gilbert Cisneros
Jul 3, 26 Buy $8K+
Julie Johnson
Jun 15, 26 Sell $8K+

Frequently Asked Questions: Abbott Laboratories (ABT)

Abbott Laboratories has an AltIndex AI Score of 61/100 (Buy). The score reflects positive alternative data signals. All investments carry risk.

61/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.

Currently, the price of one share of Abbott Laboratories (ABT) stock is $107.81 with a market cap of $187B.

As of today, Abbott Laboratories’s PE (Price to Earnings) ratio is 34.3.

View the latest Abbott Laboratories insider transactions to see recent buying and selling activity by company executives and directors.

Check the Abbott Laboratories congress trading page for the latest disclosed trades by U.S. senators and representatives.

AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.

The ABT stock price chart above shows Abbott Laboratories’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Abbott Laboratories technical analysis for RSI, moving averages, and more.

See the stocks similar to Abbott Laboratories section on this page for companies in the same industry ranked by market cap and AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.